Life expectancy of HIV-positive adults: a review

被引：70
作者：
May, Margaret T. [1 ]
Ingle, Suzanne M. [1 ]
机构：
[1] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England
来源：
SEXUAL HEALTH | 2011年 / 8卷 / 04期
基金：
英国医学研究理事会;
关键词：
aging; antiretroviral therapy; CD4; immunosuppression; prognosis; sociodemographics; COMBINATION ANTIRETROVIRAL THERAPY; HIGH-INCOME COUNTRIES; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; IMPROVED SURVIVAL; INFECTED PATIENTS; GENERAL-POPULATION; VIRAL SUPPRESSION; SAN-FRANCISCO; UNITED-STATES;
D O I：
10.1071/SH11046
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
We review studies estimating life expectancy (LE), the average number of additional years a person can expect to live, for HIV-positive adults and show variation by sociodemographic factors and level of immunosuppression. The LE of patients starting antiretroviral therapy early in the course of HIV infection and attaining restoration of a normal CD4 count may approach that of the general population. Improvements in treatment and the associated increase in LE imply that increasing numbers of HIV-positive patients will live to older age. Late diagnosis and presentation to care and treatment not concordant with guidelines contribute to reducing LE.
引用
收藏
页码：526 / 533
页数：8
相关论文
共 56 条
  • [1] Anderson J, 2008, AIDS, V22, P349, DOI 10.1097/QAD.0b013e3282f4709a
  • [2] [Anonymous], 2008, WORLD POP PROSP
  • [3] Artzrouni M, 2002, AIDS, V16, pW1
  • [4] Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4
  • [5] Back D, 2010, 10 INT C DRUG THER H
  • [6] Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations*
    Bansi, L.
    Sabin, C.
    Delpech, V.
    Hill, T.
    Fisher, M.
    Walsh, J.
    Chadborn, T.
    Easterbrook, P.
    Gilson, R.
    Johnson, M.
    Porter, K.
    Anderson, J.
    Gompels, M.
    Leen, C.
    Ainsworth, J.
    Orkin, C.
    Nelson, M.
    Rice, B.
    Phillips, A.
    [J]. HIV MEDICINE, 2010, 11 (07) : 432 - 438
  • [7] Changes in the risk of death after HIV seroconversion compared with mortality in the general population
    Bhaskaran, Krishnan
    Hamouda, Osamah
    Sannes, Mette
    Boufassa, Faroudy
    Johnson, Anne M.
    Lambert, Paul C.
    Porter, Kholoud
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (01): : 51 - 59
  • [8] A tale of two futures: HIV and antiretroviral therapy in San Francisco
    Blower, SM
    Gershengorn, HB
    Grant, RM
    [J]. SCIENCE, 2000, 287 (5453) : 650 - 654
  • [9] Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2
  • [10] Gender and the use of antiretroviral treatment in resource-constrained settings: Findings from a multicenter collaboration
    Braitstein, Paula
    Boulle, Andrew
    Nash, Denis
    Brinkhof, Martin W. G.
    Dabis, Francois
    Laurent, Christian
    Schechter, Mauro
    Tuboi, Suely H.
    Sprinz, Eduardo
    Miotti, Paolo
    Hosseinipour, Mina
    May, Margaret
    Egger, Matthias
    Bangsberg, David R.
    Low, Nicola
    [J]. JOURNAL OF WOMENS HEALTH, 2008, 17 (01) : 47 - 55
123456